Pazopanib Hydrochloride and Topotecan Hydrochloride in Treating Patients With Metastatic Soft Tissue and Bone Sarcomas

NCT02357810 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

178

Enrollment

OTHER

Sponsor class

Conditions

Adult Liposarcoma
Metastatic Liposarcoma
Metastatic Osteosarcoma
Recurrent Adult Soft Tissue Sarcoma
Recurrent Liposarcoma
Recurrent Osteosarcoma
Stage IV Adult Soft Tissue Sarcoma

Interventions

DRUG: Pazopanib Hydrochloride
DRUG: Oral Topotecan Hydrochloride
OTHER: Laboratory Biomarker Analysis

Sponsor

Northwestern University

Collaborators

[object Object]
[object Object]